1. Home
  2. CRGX vs ZKH Comparison

CRGX vs ZKH Comparison

Compare CRGX & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • ZKH
  • Stock Information
  • Founded
  • CRGX 2021
  • ZKH 1998
  • Country
  • CRGX United States
  • ZKH China
  • Employees
  • CRGX N/A
  • ZKH N/A
  • Industry
  • CRGX
  • ZKH
  • Sector
  • CRGX
  • ZKH
  • Exchange
  • CRGX Nasdaq
  • ZKH Nasdaq
  • Market Cap
  • CRGX 628.6M
  • ZKH 578.4M
  • IPO Year
  • CRGX 2023
  • ZKH 2023
  • Fundamental
  • Price
  • CRGX $3.70
  • ZKH $3.56
  • Analyst Decision
  • CRGX Hold
  • ZKH Buy
  • Analyst Count
  • CRGX 7
  • ZKH 1
  • Target Price
  • CRGX $4.67
  • ZKH $4.00
  • AVG Volume (30 Days)
  • CRGX 1.9M
  • ZKH 33.1K
  • Earning Date
  • CRGX 03-20-2025
  • ZKH 03-18-2025
  • Dividend Yield
  • CRGX N/A
  • ZKH N/A
  • EPS Growth
  • CRGX N/A
  • ZKH N/A
  • EPS
  • CRGX N/A
  • ZKH N/A
  • Revenue
  • CRGX N/A
  • ZKH $1,259,541,805.00
  • Revenue This Year
  • CRGX N/A
  • ZKH $0.49
  • Revenue Next Year
  • CRGX N/A
  • ZKH $12.88
  • P/E Ratio
  • CRGX N/A
  • ZKH N/A
  • Revenue Growth
  • CRGX N/A
  • ZKH 3.49
  • 52 Week Low
  • CRGX $3.00
  • ZKH $2.62
  • 52 Week High
  • CRGX $33.92
  • ZKH $21.91
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 20.88
  • ZKH 50.21
  • Support Level
  • CRGX $3.00
  • ZKH $3.50
  • Resistance Level
  • CRGX $3.88
  • ZKH $3.70
  • Average True Range (ATR)
  • CRGX 0.92
  • ZKH 0.20
  • MACD
  • CRGX -1.00
  • ZKH -0.00
  • Stochastic Oscillator
  • CRGX 5.99
  • ZKH 16.05

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About ZKH ZKH Group Limited each representing thirty-five (35)

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

Share on Social Networks: